Evidence map›Paper›PMID 37345068›Full record

ArticleCancers2023

Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1

Marica De Cicco, Ivana Lagreca, Sabrina Basso, Patrizia Barozzi, Stella Muscianisi, Alba Bianco, Giovanni Riva, Sara Di Vincenzo, Chiara Pulvirenti, Davide Sapuppo and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Marica De CiccoSSD Cell Factory e Center for Advanced Therapies, Department of Woman and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Ivana LagrecaSection of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Modena, 41124 Modena, Italy.ORCID 0000-0002-2864-097X
Sabrina BassoSSD Cell Factory e Center for Advanced Therapies, Department of Woman and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Patrizia BarozziSection of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Modena, 41124 Modena, Italy.ORCID 0000-0002-8936-1114
Stella MuscianisiSSD Cell Factory e Center for Advanced Therapies, Department of Woman and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Alba BiancoSSD Cell Factory e Center for Advanced Therapies, Department of Woman and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Giovanni RivaDepartment of Laboratory Medicine and Pathology, Unità Sanitaria Locale, 41126 Modena, Italy.ORCID 0000-0003-2089-6230
Sara Di VincenzoSSD Cell Factory e Center for Advanced Therapies, Department of Woman and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.ORCID 0009-0009-0700-119X
Chiara PulvirentiSSD Cell Factory e Center for Advanced Therapies, Department of Woman and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Davide SapuppoSSD Cell Factory e Center for Advanced Therapies, Department of Woman and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Mariangela SicilianoSSD Cell Factory e Center for Advanced Therapies, Department of Woman and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Vittorio RostiCenter for the Study of Myelofibrosis, General Medicine 2, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.ORCID 0000-0003-4195-2289
Anna CandoniSection of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Modena, 41124 Modena, Italy.ORCID 0000-0003-4436-1310
Marco ZeccaSC Pediatric Hematology/Oncology, Department of Woman and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.ORCID 0000-0002-8818-1744
Fabio ForghieriSection of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Modena, 41124 Modena, Italy.
Mario LuppiSection of Hematology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Modena, 41124 Modena, Italy.
Patrizia ComoliSSD Cell Factory e Center for Advanced Therapies, Department of Woman and Child Health, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.ORCID 0000-0001-5964-0553
Policlinico San Matteo Fondazione · ITUniversity of Modena and Reggio Emilia · ITAzienda Unita' Sanitaria Locale Di Modena · IT

Funding

Associazione Italiana Lotta alle Leucemie, Linfoma e Mieloma (AIL)-Sezione "Luciano Pavarotti"-Modena-ONLUS "Charity Dinner Initiative" in memory of Alberto FontanaAssociazione Italiana per la Ricerca sul Cancro (AIRC) IG project #20624Fondazione Regionale per la Ricerca Biomedica (FRRB, Regione Lombardia) Project N° CP2_10/2018Italian Ministry of Health, Ricerca Corrente Fondazione IRCCS Policlinico San Matteo 08069119 to PC and 08045818 to MZMIUR 2017 Progetto Dipartimenti di EccellenzaPNRR CN3 Terapia Genica-Spoke 2 Project #CN00000041Regione Lombardia Project POR FESR 2526393 FORCE-4-CURE
6 · The paper itself

Abstract

Acute myeloid leukemia (AML) with nucleophosmin (

Indexed as

acute myeloid leukemiahematopoietic stem cell transplantationminimal residual diseaseNPM1 mutationT cell therapy

Identifiers

PMID37345068
PMCPMC10216567
OpenAlexW4376275184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.